Skip to content
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
TNC FlipBook Classic items
2025-02_Letter_to_shareholders-Biophytis_EN
By
admin
February 10, 2025
2025-02-04_INVEST_SECURITIES-ETUDE_BIOPHYTIS
By
admin
February 10, 2025
27-01-25_PR_Participation_BioMed
By
admin
January 26, 2025
27-01-25_CP_Participation_BioMed
By
admin
January 26, 2025
20250121_PR_Biophytis_AskHelpU_EN
By
admin
January 20, 2025
20250121_CP_Biophytis_AskHelpU_FR
By
admin
January 20, 2025
2025-01-14_PR_Biophytis_Partnership_China_EN
By
admin
January 13, 2025
2025-01-14_CP_Biophytis_Partenariat_Chine_FR
By
admin
January 13, 2025
2025-01-08_PR_Biophytis_Refinancing_Transaction_EN
By
admin
January 7, 2025
2025-01-08_CP_Biophytis_Operation_Refinancement_FR
By
admin
January 7, 2025
←
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
…
24
25
26
27
28
…
29
30
31
32
33
34
→
Go to Top
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
